Wang Yu

2005-2013 (2011 -2013 ) 2013 -2017 8 (2015 7 -2016 7 ) 2017 9 - 2022 8 - 、,,. 2016 (AAA)、2017 (IFOS)、2018 (Ci2018). 、,, 5.2020. 《 》 《BJSM 》 (GBD collaborator) (YO-IFOS) 2022 2022 ” 2021 2021 2021 “ ”, 2019 Xie Y, Wang Y, Pan T, Tyler RS. Validation of the Chinese Translation of the "Meaning of Life" in Patients with Hearing Loss or Tinnitus. J Am Acad Audiol. 2022 Dec 10. doi: 10.1055/a-1996-1227.,,,,. [J].,2021,19(04):577-581.,,,. [J]., 2020, 55(8): 748-753.,,. CT [J]., 2020, 51(5): 683-689. Wang Y, Pan T, Ma F R, et al. Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant[J]. Chinese Medical Journal, 2019, 132: 100-102.,,,,. ABR EABR [J],, 2018, 16(6): 801~805.,,,. [J]., 2017, 15(4): 431-435. Wang Yu, Pan Tao, Shruti Balvalli Deshpande, Ma Furong. The relationship between EABR and auditory performance and speech intelligibility outcomes in pediatric cochlear implant recipients[J]. American Journal of Audiology. 2015,24(2): 226-234.,,. [J].,2015,(3):469-475.,,,. EABR [J].. 2013,27(1):8-12.,,,. [J].. 2013(5):465-468.